Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

HQ
One Kendall Square,
Suite B3301
Cambridge, MA, 02139
USA

People

Chief Executive Officer
Co-Founder and BOD member
Chief Financial Officer
Vice President, Legal
Vice President, Research
Vice President, Strategic Product Development
President and CEO
Board of Directors
Show All People

Funding

TOTAL $37.4M
FUNDING TOTAL $37.4M
Venture Round, 12/2009
$3.2M
Series A, 11/2012
Omega Funds
Polaris Partners
Flagship Ventures
Lux Capital
Bill & Melinda Gates Foundation
$26.1M
Series A, 12/2013
Polaris Partners
Flagship Ventures
Lux Capital
Omega Funds
Bill & Melinda Gates Foundation
$8.1M
DEBT TOTAL $6M
Debt, 8/2010
Flagship Ventures
Lux Capital
Polaris Partners
$6M

Tags

Visterra

Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. Visterra Raises $8.1M in Series A Round (finsmes.com) [edit]
Edit This Page
Last Edited 1/29/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy